|
Medical & Scientific Advisory Board
|
This prestigious group of scientists,
clinicians, and academicians were invited to serve on the Scientific Advisory Board because they are recognized as
experts in various areas of iron metabolism and genetics. Their expertise includes such disorders of iron as
hereditary hemochromatosis/iron overload, anemia of chronic disease, iron deficiency anemia, African siderosis,
thalassemia, sideroblastic anemia and other conditions of iron balance. These scientists were offered in name by
peers to IDI Board of Trustees for consideration to serve as expert advisors assuring accuracy of information of
IDI publications and ongoing research of iron metabolism. |
|
 | |
Chair, Scientific Advisory Board
HERBERT BONKOVSKY, M.D., VP for Research Carolinas Health Care System
Professor, University of Connecticut;
Professor, University of North Carolina
Carolina's Health Care System
Dr. Bonkovsky is world renowned for his work in digestive diseases and metabolism. He is an expert
in disease such as the Porphyrias, NASH (non-alcoholic steatohepatitis), viral hepatitis, cirrhosis,
liver tumor and cancer. He has served on consensus committees addressing issues about liver disease
and formulating treatment policies that remain the gold standard. |
|
 |
| Vice Chair, Scientific Advisory Board
P.D. PHATAK, M.D. Hematology
Rochester General Hospital
Dr. Phatak is renown for his work in cost effectiveness of screening for hemochromatosis/ iron overload. His contributions in this
area have been recognized by the Centers for Disease Control and Prevention and remain significant reference for scientists around
the world. As the Medical Director of Mary Gooley Hemophilia Center,
Rochester NY and head of Hematology/Oncology department
Rochester General he contributes daily to diagnosis and treatment of those with disorders of iron. |
|
 |
| JOHN LONGSHORE, Ph.D Director of Laboratory Services and Genetics
Carolina Medical Center, Charlotte, NC.
Dr. Longshore is an expert in molecular analysis. His findings in progress include possibility of higher
prevalence of HFE mutation for hemochromatosis in the southern region on US population and occurrence of
C282Y in non-whites. |
|
 |
| DAVID MEYERS, M.D., M.P.H., Department of Medicine, Division of Cardiovascular Disease
Kansas University College of Medicine
Dr. Meyers is expert in cardiovascular disease. His more-than-two decades of work includes writing Kansas Primary
Care Physicians Preventive Health Guidelines. He provides scientific substantiation of a connection to reduced
incidence of cardiac arrest and frequency of blood donation. |
|
 |
| JOHN BEARD, Ph.D., Professor of Nutrition
Pennsylvania State University
Dr. Beard has studied the effects of iron deficiency on cognitive and behavioral performance, thyroid metabolism
and thermo-regulation for more than twenty years. His work includes investigating benefits of iron supplementation
in youths, women of childbearing age and the elderly. |
|
 |
| MARK PRINCELL,M.D., Director Emergency Room Services
St. Francis Health System
Dr. Princell manages services for two major emergency room facilities. His knowledge of hemochromatosis/iron overload
spans more than a decade. His current work in progress includes "Suspect Hemochromatosis: Guidelines for Emergency
Health Care Providers." |
|
 |
| JUKKA SALONEN, M.D., Ph.D., Department of Medicine
University of Kuopio
Dr. Salonen conducted the first major study of incidence of cardiac arrest in males relative to ferritin levels. His
ongoing work includes incidence of cardiac arrest in heterozygotes. |
|
 |
| KRIS KOWDLEY, M.D., Department of Medicine
University of Washington, Seattle
Dr. Kowdley is a practicing hepatologist expert in liver transplantation. His interest in the role of hemochromatosis
and the liver led him to organize and open the first Hemochromatosis/Iron Disorders Clinic in the US. He has written
extensively about liver transplantation and is respected throughout the world for his work in this field. |
|
 |
| JAMES CONNOR, Ph.D., Professor and Vice Chair, Department of Neuroscience & Anatomy, M.C. H 109 Director G.M. Leader
Alzheimer's Disease Research Laboratory
Dr. Connor is recognized as an expert in the relationship between iron and neuro-degenerative diseases. He is one of the
first to make an association between hemochromatosis/ iron overload and depression. His current work includes having
identified an antibody to the divalent metal transporter DMT1 believed to play a significant role in iron absorption. |
|
 |
| ANN AUST, Ph.D., Department of Chemistry and Biochemistry
Utah State University
Dr. Aust is an expert in inhaled carcinogenic materials such as iron containing asbestos and other particulants inherent in
today's environment. Her work is cutting edge and garnering attention by those interested in the relationship of iron and cancer. |
|
 |
| EUGENE WEINBERG, Ph.D., Professor of Microbiology
Indiana University
Dr. Weinberg is a leading expert in infectious disease and cancer. His work focuses on prevention of chronic disease by reducing iron
levels by reducing intake of iron in diet and discontinuing contributive factors such as tobacco use and alcohol. His more than forty
years work in the field of iron's relationship to cancer has earned him prestige and recognition worldwide. His recent paper in
Emerging Infectious Diseases (Iron Loading and Disease Surveillance),
a new CDC publication, is among over a hundred excellent articles he has written on the subject of
iron and its carcinogenic and oxidant capabilities. |
|
 |
| BARRY SKIKNE, M.D., Department of Medicine
Kansas University College of Medicine
Dr. Skikne is expert in iron balance: excess or insufficiency. His more than twenty-five years in the field
includes pioneer work on the serum transferrin receptor--one of the most sophisticated diagnostic revelations
of the decade. |
|
 |
| Joanne Jordan, M.D., M.P.H., Associate professor of Medicine and Epidemiology
Thurston Arthritis Research Center University of North Carolina, Chapel Hill
Dr. Jordan sees patients and conducts research about arthritis. One of her most recent research projects is to
study the links among osteoarthritis and anxiety and depression. Dr. Jordan is a leading expert in hemochromatosis
arthritis. |
|
 |
| PATRICK MACPHAIL, M.D., Ph.D., Emmanuel and Robert Hart Professor of Bioethics
University of Witwatersrand - Johannesburg, South Africa
Dr. MacPhail is expert in African siderosis. His work includes research of relationship of iron overload and
genetics in Africans. |
|
 |
| Arthur Caplan, Ph.D, Department of Medicine
University of Pennsylvania
Dr Caplan is the Emmanuel and Robert Hart Professor of Bioethics, Chair of the Department of Medical Ethics
and the Director of the Center for Bioethics
at the University of Pennsylvania in Philadelphia. Caplan is the author
or editor of twenty-five books and over 500 papers in refereed journals of medicine, science, philosophy, bioethics
and health policy. He writes a regular column on bioethics
for MSNBC.com. He is a frequent guest and commentator on
National Public Radio, Nightline, CNN, MSNBC, Fox, CBS, the New York Times, Washington Post, Philadelphia Inquirer
and many other media outlets. |
|
 |
| Lewis Wesselius, M.D., Senior Associate Consultant Division
of Pulmonary Medicine
Mayo Clinic Scottsdale, AZ
University of Kansas School of Medicine, Kansas City, KS.
Internship: University of Arizona Medical Center, Tucson, Ariz. Residency: Internal Medicine, University of
Arizona, Tucson, Ariz. Fellowship: Pulmonary Fellowship, University of California, San Diego, Calif. Interests:
Airways Disease, Lung Cancer, Occupational Lung Disease, Interstitial Lung Disease and Cystic
Fibrosis. |
|
 |
| Robert T. Means, Jr., M.D., Professor of Hematology/Oncology
University of Kentucky and the VA Medical Center
He is a graduate of Vanderbilt University College of Medicine, Nashville, Tenn and Baylor College of
Medicine, Texas Medical Center, Houston, Texas. His special interests include anemia, benign hematology, red
cell disorders and diagnostic hematology. |
|
 |
| Mark W. Wurster, M.D., OSU Internal Medicine at Grove City
Ohio State University College of Medicine
Dr. Wurster received his credentials from Brown University in 1982, and served his residency at the University of Kansas in 1985. Dr.
Wurster then received a Hematology fellowship from University of Kansas in 1987. Dr. Wurster specialized in disease management, computerized
decision support, and hemochromatosis.
|
|
 |
|
George Bartzokis M.D.
David Geffen School of Medicine at UCLA
Department of Neurology
http://faculty.bri.ucla.edu/institution/personnel?personnel_id=8435
Dr. Bartzokis specializes in iron management in the brain; he is a member of the Brain Research Institute at UCLA. His interests include memory disorders, age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Dr. Bartzokis is the inventor of the MRI technique used to view brain iron.
|
|
 |
|
Arch "Chip" Mainous III, Ph.D.
Medical University of South Carolina
http://www.musc.edu
Dr. Mainous obtained his PhD from the University of Texas and spent 8 years as director of research in the Department of Family Medicine before joining the Department of Family Medicine at MUSC 1998. He currently serves as Director of Research in the department. Dr. Mainous' research interests are in diabetes and cardiovascular health, treatment of respiratory infections, and continuity of care. Dr. Mainous has published several articles that report important iron related findings, including that biochemical markers for iron overload, alone and when combined with other risk factors, can increase the potential for premature death, cancers and Alzheimer's disease.
|
|
|
